Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ASAP1 intronic transcript 2 (ASAP1-IT2) is a long non-coding RNA transcribed from the intronic region of the ASAP1 gene. It does not code for protein and is primarily classified among regulatory lncRNAs; its specific biological function, disease association, and relevance to drug targeting are currently poorly described in the biomedical literature[4][1]. Additional notes: - Context from ASAP1-IT1: ASAP1-IT1, another intronic transcript of ASAP1, is known to regulate ovarian cancer cell proliferation and apoptosis by sponging miR-2278 and modulating LATS2/YAP1 signaling[2]. The lack of functional data for ASAP1-IT2 means that potential roles cannot be ruled out but cannot be assumed. - Relationship to ASAP complexes: While the ASAP complex involves proteins related to splicing regulation[3], ASAP1-IT2 is a transcript and not a proteinaceous complex component. Summary: ASAP1-IT2 is a non-protein-coding RNA gene, not currently considered a classic therapeutic target, with no established biological functions, disease roles, or drug interactions in peer-reviewed sources as of this search[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ASAP1 intronic transcript 2 (non-protein coding) (ASAP1-IT2).